Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: Q
2011
PHARMAC documents that matched your search:
Schedule Update - effective 1 January 2012
(37 pages, 631 KB)
2011/12/16
“Q Q 200 ................................................................ 33 Quinine sulphate ................................................ 33 R Remifentanil-AFT................................................ 33 Remifentanil hydrochloride ................................. 33 S Sodium”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January 2012 Section H cumulative for December 2011 and January 2012 Contents Summary of Pharmac decisions effective 1 January 2012 … 3 Subsidy changes for some respiratory inhalation products and…
Dabigatran: questions and answers
(5 pages, 97 KB)
2011/10/31
“Q and A, dabigatran Did PHARMAC's funding decision include a review of international trial”
Background on PHARMAC’s decision to fund dabigatran What was the rationale for PHARMAC's decision to fund dabigatran? Doctors have long sought an effective alternative to warfarin to treat patients needing anticoagulant therapy. Warfarin is a drug that is difficult…
Schedule Update - effective 1 February 2011
(47 pages, 692 KB)
2011/01/18
“Q 300 Mycobutin Ropin ArrowRoxithromycin Salapin Asthalin Asthalin Duolin 2012 2013 2013 2012 2013 2012 2012 2011 2011 2012 2011 2012 2012 2011 2012 2011 2011 2011 Quinapril”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February 2011 Cumulative for January and February 2011 Section H cumulative for December 2010, January and February 2011 Contents Summary of PHARMAC decisions - effective 1 February 2011 ….. 3…
Schedule Update - effective 1 April 2011
(81 pages, 821 KB)
2011/03/17
“Q 300 Mycobutin Ropin ArrowRoxithromycin 2012 2013 2013 2012 2012 2012 2012 2011 2011 2012 2011 2012 2012 2011 2012 2011 2011 2011 31/12/12”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April 2011 Cumulative for January, February, March and April 2011 Section H for April 2011 Contents Summary of PHARMAC decisions effective 1 April 2011 …. 3 Christchurch Earthquake …. 6…
Schedule Update - effective 1 December 2011
(76 pages, 769 KB)
2011/11/17
“Q Q 200 ......................................................... 69, 71 Quinine sulphate ......................................... 69, 71 R Remifentanil-AFT............................................... 71 Remifentanil hydrochloride”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2011 Cumulative for September, October, November and December 2011 Section H for December 2011 Contents Summary of PHARMAC decisions effective 1 December 2011 ….. 3 Medicines Regulation Changes…. 5…
Schedule Update - effective 1 March 2011
(59 pages, 739 KB)
2011/02/18
“Q 300 Mycobutin Ropin ArrowRoxithromycin 2012 2013 2013 2012 2012 2012 2012 2011 2011 2012 2011 2012 2012 2011 2012 2011 2011 2011 31/12/12”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March 2011 Cumulative for January, February and March 2011 Section H cumulative for December 2010, January, February and March 2011 Contents Summary of PHARMAC decisions effective 1 March 2011 …..…
Schedule Update - effective 1 July 2011
(74 pages, 1697 KB)
2011/06/16
“Q 300 Mycobutin Ropin ArrowRoxithromycin Salapin Asthalin Asthalin Duolin 2012 2012 2012 2012 2012 2012 2012 2012 2013 2013 2012 2013 2012 2012 31/12/12”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2011 Cumulative for May, June and July 2011 Section H cumulative for April, May, June and July 2011 Contents Summary of PHARMAC decisions effective 1 July 2011 … 3…
Section H - effective 1 July 2011
(80 pages, 560 KB)
2011/06/29
“Q 200 Q 300 Evista Isentress Arrow-Ranitidine Arrow-Ranitidine Peptisoothe Zantac Advate Kogenate FS Xyntha”
Pharmaceutical Management Agency Section H for Hospital Pharmaceuticals Effective 1 July 2011 New Zealand Pharmaceutical Schedule Hospital Pharmaceuticals July 2011 Editors Kaye Wilson & Rebecca Bloor email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9,…
Section H - effective 1 November 2011
(82 pages, 608 KB)
2011/10/31
“Q 200 Q 300 Evista Isentress Arrow-Ranitidine Arrow-Ranitidine Peptisoothe Zantac BeneFIX BeneFIX BeneFIX”
Pharmaceutical Management Agency Section H for Hospital Pharmaceuticals Effective 1 November 2011 New Zealand Pharmaceutical Schedule Hospital Pharmaceuticals November 2011 Editors Kaye Wilson & Rebecca Bloor email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9,…
Schedule Update - effective 1 October 2011
(66 pages, 874 KB)
2011/09/16
“Q 300 Peptisoothe Arrow-Ranitidine Mycobutin Ropin ArrowRoxithromycin Salapin Asthalin Asthalin Duolin 2014 2014 2012 2014 2013 2013 2012 2013 2012 2012 Salbutamol”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2011 Cumulative for September and October 2011 Section H cumulative for August, September and October 2011 Contents Summary of PHARMAC decisions effective 1 October 2011 ….. 3 Special Authority…
